Texas Unveils Five-Year Roadmap to Eliminate Cervical Cancer by 2032

In a bold bid to wipe out one of the most preventable malignancies in medicine, a statewide coalition led by The University of Texas MD Anderson Cancer Center has unveiled the Texas Lone Star Cervical Cancer Elimination Plan 2027-2032, a five-year roadmap designed to drive cervical cancer incidence in Texas below the threshold that public health experts define as elimination. The plan was announced on October 7, 2026, at the Cancer Prevention and Research Institute of Texas (CPRIT) 2026 Innovations Conference in Galveston, where coalition leaders from health systems, academic institutions, community organizations and advocacy groups gathered to formally commit to a shared target: fewer than four new cases of cervical cancer per 100,000 women per year.

The urgency behind the initiative is grounded in stark numbers. Texas currently records a cervical cancer incidence rate of 9.5 per 100,000 women, well above the national figure of 7.5 per 100,000. The state ranks eighth in the nation for incidence and sixth for mortality, a combination that signals not only more diagnoses but also worse outcomes for the women who receive them. The disparities run even deeper at the county level, where some Texas communities report incidence rates between 15 and 21 per 100,000 — as much as five times the elimination threshold. The burden falls disproportionately on uninsured women, rural residents, border communities and minority populations, groups that historically face the greatest barriers to vaccination, screening and follow-up care.

Cervical cancer occupies a unique position in oncology: it is one of the few cancers for which near-complete prevention is scientifically achievable. Virtually every case is caused by persistent infection with high-risk types of human papillomavirus (HPV), a common sexually transmitted virus against which highly effective vaccines have existed since 2006. When precancerous lesions are detected through screening and treated promptly, progression to invasive cancer can be interrupted almost entirely. The World Health Organization has embraced this logic globally, setting the same sub-four-per-100,000 threshold as its international elimination benchmark. The Texas plan translates that global framework into a state-specific strategy, acknowledging that the biology of prevention is settled and the remaining challenge is one of delivery, access and follow-through.

The plan was developed by the Cancer Alliance of Texas Cervical Cancer Elimination Priority Area Workgroup, which grounded its recommendations in a survey of stakeholders across the state and a virtual summit that drew more than 250 participants. The resulting document aligns with multiple priorities from the 2024 Texas Cancer Plan, ensuring that the elimination effort is embedded within the state’s broader cancer control architecture rather than operating as a standalone campaign. More than 40 coalition members have already signed a joint declaration outlining their individual commitments, a structure that distributes responsibility across hospitals, clinics, schools, funders and community organizations instead of concentrating it in a single institution.

At the heart of the roadmap are three pillars, each paired with a measurable target for 2032. The first addresses HPV vaccination: the plan calls for raising the percentage of Texas boys and girls who are up to date on HPV vaccination by age 15 from 50.5 percent to 80 percent. That figure matters because vaccination is most protective when administered well before any potential exposure to the virus, and the age-15 benchmark reflects national guidance emphasizing early completion of the vaccine series. Vaccinating both boys and girls is critical, since herd immunity depends on broad coverage across the population and males can carry and transmit the virus even when they face far lower personal risk of HPV-driven cancers themselves.

The second pillar targets screening, with the goal of increasing the share of Texas women who are up to date on cervical cancer screening from 64 percent to 80 percent. The plan explicitly incorporates two technological advances designed to lower the barriers that keep women from being tested. Primary HPV testing, which uses the virus itself as the screening signal rather than relying solely on cytology, offers improved sensitivity and longer intervals between tests. HPV self-collection, meanwhile, allows women to gather their own samples in a clinical setting or potentially outside traditional exam rooms, an option that has shown promise in reaching women who avoid screening because of discomfort, cost, time constraints or distrust of the medical system. Adding these modalities to the state’s screening toolkit is one of the plan’s most consequential technical commitments.

The third pillar confronts a step that is often overlooked in elimination strategies: what happens after an abnormal result. The plan aims to ensure that 80 percent of women receive the diagnostic follow-up and treatment they need when screening detects something suspicious. This stage is where many prevention programs falter, because an abnormal screening result is only the beginning of a cascade that may involve colposcopy, biopsy and treatment of precancerous lesions. Each additional appointment is an opportunity for patients to be lost to the system, particularly among women juggling work, childcare, transportation challenges or lack of insurance. The plan addresses this vulnerability through community outreach, patient navigation, provider training and survivorship support, pairing clinical capacity with human infrastructure that guides patients through every step.

Patient navigation and access expansion are not confined to a single pillar; they are woven across all three, with particular emphasis on rural and border communities and on including people without health insurance. This design choice reflects the epidemiology of the disease in Texas, where geographic and economic isolation translate directly into higher incidence and mortality. Community health workers, known in many Texas communities as promotores, are positioned as central actors in the strategy, bridging the gap between formal health systems and neighborhoods where medical mistrust, language barriers and logistical hurdles suppress participation in vaccination and screening programs.

Coalition leaders framed the effort in explicitly human terms. Ernest Hawk, M.D., vice president and division head of Cancer Prevention and Population Sciences at UT MD Anderson, said that Texas has the tools to prevent nearly every case of cervical cancer but that tools save lives only when people can utilize them. He described the plan as a shared roadmap to vaccinate more children, screen more women and ensure that every abnormal result leads to care, adding that with innovations like HPV self-collection and the commitment of partners across the state, elimination is within reach. Sharyn Malatok, chair of the Cancer Alliance of Texas, emphasized that elimination will happen in clinics, schools, churches and neighborhoods, through community health workers, promotores and navigators who meet people where they are, and that the plan puts those communities at the center of the effort.

The six-year timeline gives the coalition a concrete horizon: if the 2032 targets are met, Texas would join the small group of jurisdictions that have pushed cervical cancer below the elimination threshold, transforming a disease that once killed thousands of American women annually into a rarity detectable only through surveillance. The full plan is publicly available at TexasCancerPlan.org/CCEP, and its architects are calling on policymakers, health systems, schools, funders and community leaders across the state to join the effort. Whether Texas reaches the finish line will depend on sustained funding, vaccination uptake among the state’s large and diverse pediatric population, and the unglamorous work of making sure no abnormal result slips through the cracks — but for the first time, the state has a single, quantified roadmap for getting there.

Subject of Research: A statewide public health plan to eliminate cervical cancer in Texas through HPV vaccination, screening and timely follow-up care

Article Title: New statewide plan aims to eliminate cervical cancer in Texas by 2032

Article References: New statewide plan aims to eliminate cervical cancer in Texas by 2032. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: cervical cancer, HPV vaccination, cancer screening, Texas, MD Anderson, CPRIT, public health, health disparities, HPV self-collection, patient navigation, cancer elimination, preventive oncology